| 1 | % | 764,873 |
| 2 | gm/m2 | 12 |
| 3 | cm/cm² | 8 |
| 4 | y/o | 8 |
| 5 | 083 | 6 |
| 6 | doth | 6 |
| 7 | meq/100g | 6 |
| 8 | ng*hour/ml | 6 |
| 9 | nmol·l | 6 |
| 10 | emu/g | 5 |
| 11 | micromol/kg/day | 5 |
| 12 | months/patient | 4 |
| 13 | nmol/kg.day-1 | 4 |
| 14 | ntu/ml | 4 |
| 15 | smd-pds | 4 |
| 16 | eu/liter | 3 |
| 17 | joules/point | 3 |
| 18 | kg/hm2n | 3 |
| 19 | log10/g | 3 |
| 20 | mg/gcdw.h | 3 |
| 21 | mgh/l | 3 |
| 22 | mmhg·min | 3 |
| 23 | post-clp | 3 |
| 24 | v194 | 3 |
| 25 | μg/ml*h | 3 |
| 26 | bts/min | 2 |
| 27 | caps/mm2 | 2 |
| 28 | cfhn | 2 |
| 29 | cigs/d | 2 |
| 30 | cryotreatments | 2 |
| 31 | days/person | 2 |
| 32 | days/person-year | 2 |
| 33 | g/m/hr | 2 |
| 34 | g/supplement | 2 |
| 35 | gv/cm | 2 |
| 36 | g·°c·min | 2 |
| 37 | injections/month | 2 |
| 38 | interactions/patients | 2 |
| 39 | kj.3.5 | 2 |
| 40 | mcg·kg-1·d-1 | 2 |
| 41 | mg*hr/l | 2 |
| 42 | mg/animal/day | 2 |
| 43 | mg/g·cr | 2 |
| 44 | mg/km | 2 |
| 45 | mgfemnp | 2 |
| 46 | mgy.cm | 2 |
| 47 | microns2 | 2 |
| 48 | millions/ml | 2 |
| 49 | ml.m-2.h-1 | 2 |
| 50 | ml·min-1·kg-1 | 2 |
| 51 | mm²/min | 2 |
| 52 | months/hrt | 2 |
| 53 | mothers-infants | 2 |
| 54 | mu/m2/week | 2 |
| 55 | n/cm² | 2 |
| 56 | ng/microu | 2 |
| 57 | ngy/h | 2 |
| 58 | pkat/mg | 2 |
| 59 | residents/program | 2 |
| 60 | u/horse/day | 2 |
| 61 | units/dl | 2 |
| 62 | utis/patient | 2 |
| 63 | uygurs | 2 |
| 64 | μg/8h | 2 |
| 65 | μmoles/liter | 2 |
| 66 | +/-1.11 | 1 |
| 67 | +/-1.23 | 1 |
| 68 | +/-1.63 | 1 |
| 69 | +/-11.06 | 1 |
| 70 | +/-15.0cm/second | 1 |
| 71 | +/-17.8 | 1 |
| 72 | +/-23.9 | 1 |
| 73 | +/-23.90 | 1 |
| 74 | +/-3.33 | 1 |
| 75 | +/-4.81 | 1 |
| 76 | +/-6.78 | 1 |
| 77 | +/-8.92 | 1 |
| 78 | +0.3±5.8 | 1 |
| 79 | +2.10 | 1 |
| 80 | -/+11.8 | 1 |
| 81 | /+2.1 | 1 |
| 82 | /205 | 1 |
| 83 | /350 | 1 |
| 84 | 051.90 | 1 |
| 85 | 1.65-6.23 | 1 |
| 86 | 107+/-28.2 | 1 |
| 87 | 1361±405 | 1 |
| 88 | 1¯ | 1 |
| 89 | 205143 | 1 |
| 90 | 205402 | 1 |
| 91 | 207.76 | 1 |
| 92 | 287.12 | 1 |
| 93 | 34.4+/-3.5 | 1 |
| 94 | 38304-91-5 | 1 |
| 95 | 40.1±4.6 | 1 |
| 96 | 42430 | 1 |
| 97 | 49-1.22 | 1 |
| 98 | 642/µl | 1 |
| 99 | 75+/-19.7 | 1 |
| 100 | 763±3059 | 1 |
| 101 | 8.27±7.33 | 1 |
| 102 | 818.05±16 | 1 |
| 103 | 9/700 | 1 |
| 104 | =0.235-1.810 | 1 |
| 105 | adenocarciomas | 1 |
| 106 | african-american/101 | 1 |
| 107 | albendazole-allocated | 1 |
| 108 | alexandrine | 1 |
| 109 | angstroms/s | 1 |
| 110 | balloons/case | 1 |
| 111 | bpm/d | 1 |
| 112 | breaks/day | 1 |
| 113 | broilers/trial | 1 |
| 114 | bursts/minute | 1 |
| 115 | cal/kg/d | 1 |
| 116 | calories/kg/d | 1 |
| 117 | cases/1291 | 1 |
| 118 | cells/µl/year | 1 |
| 119 | cially | 1 |
| 120 | cmlcs | 1 |
| 121 | conrols | 1 |
| 122 | cyathiformis | 1 |
| 123 | cysts/animal | 1 |
| 124 | days.. | 1 |
| 125 | days/5.5 | 1 |
| 126 | deceased/moved | 1 |
| 127 | dilution-units | 1 |
| 128 | dyn.cm.5 | 1 |
| 129 | edlund | 1 |
| 130 | electrocutions | 1 |
| 131 | embryo/recovery | 1 |
| 132 | euro+/-539 | 1 |
| 133 | female/158 | 1 |
| 134 | females/74 | 1 |
| 135 | femtoliters | 1 |
| 136 | fibers/high | 1 |
| 137 | fibrillations/min | 1 |
| 138 | fmol/l | 1 |
| 139 | g/capsule | 1 |
| 140 | g/days | 1 |
| 141 | g/hm2 | 1 |
| 142 | g/kg.d | 1 |
| 143 | g/km/mo | 1 |
| 144 | g/m2/hour | 1 |
| 145 | g/patient | 1 |
| 146 | g/visit | 1 |
| 147 | g/°c | 1 |
| 148 | gene-transcripts | 1 |
| 149 | girls/boys | 1 |
| 150 | gly/ser+ser/ser | 1 |
| 151 | gpl-u/ml | 1 |
| 152 | gy/32 | 1 |
| 153 | gy/37 | 1 |
| 154 | hallucinogen-naïve | 1 |
| 155 | hr*ng/l | 1 |
| 156 | injections/cord | 1 |
| 157 | insa | 1 |
| 158 | interventio | 1 |
| 159 | introns/gene | 1 |
| 160 | iti-esthetic | 1 |
| 161 | k/gm2 | 1 |
| 162 | kb/s | 1 |
| 163 | kg-1·m-2 | 1 |
| 164 | kj/mole | 1 |
| 165 | kjmol-1 | 1 |
| 166 | kton/year | 1 |
| 167 | kω/□ | 1 |
| 168 | l/carcass | 1 |
| 169 | l/mn/m2 | 1 |
| 170 | landsnails | 1 |
| 171 | lipil® | 1 |
| 172 | liters/min.m2 | 1 |
| 173 | lmethane/kgbagasse | 1 |
| 174 | lymphatics/high | 1 |
| 175 | m-ramirez | 1 |
| 176 | m/35f | 1 |
| 177 | macrophages/high | 1 |
| 178 | macrostemonis | 1 |
| 179 | male-45 | 1 |
| 180 | males/43 | 1 |
| 181 | may2005 | 1 |
| 182 | mc/da | 1 |
| 183 | mc/m2 | 1 |
| 184 | measurements/patient | 1 |
| 185 | men/109 | 1 |
| 186 | mg/dl+/-1.5 | 1 |
| 187 | mg/lf | 1 |
| 188 | mg/mm | 1 |
| 189 | mgi/kg/s | 1 |
| 190 | mgn/l | 1 |
| 191 | mg·h/ml | 1 |
| 192 | mg×h/dl | 1 |
| 193 | microcarcinomata-1 | 1 |
| 194 | microg./min | 1 |
| 195 | microl/s | 1 |
| 196 | micromol/l/min | 1 |
| 197 | micromoles/l | 1 |
| 198 | millett | 1 |
| 199 | million/l | 1 |
| 200 | million/sample | 1 |
| 201 | min/hr/patient | 1 |
| 202 | min=treatment | 1 |
| 203 | mini-pbals | 1 |
| 204 | minutes+/-1.0 | 1 |
| 205 | minutes+/-1.8 | 1 |
| 206 | minutes/attack | 1 |
| 207 | mj/week | 1 |
| 208 | ml/kg/min+/-8.6 | 1 |
| 209 | ml/kgmin | 1 |
| 210 | mm.hg | 1 |
| 211 | mm/1.2° | 1 |
| 212 | mmeq/l | 1 |
| 213 | mmhg+3.2 | 1 |
| 214 | mmhg+3.8 | 1 |
| 215 | mmhg/dbp-13.0 | 1 |
| 216 | mmhg/min/l | 1 |
| 217 | mmhg2 | 1 |
| 218 | mmhg² | 1 |
| 219 | mpl-u/ml | 1 |
| 220 | mrem/mci | 1 |
| 221 | ms/∞ | 1 |
| 222 | mtechnetium | 1 |
| 223 | mu-g/12 | 1 |
| 224 | mu/dl | 1 |
| 225 | mu/minutes | 1 |
| 226 | mumol/minute | 1 |
| 227 | mw.cm-3 | 1 |
| 228 | mxs-2 | 1 |
| 229 | nanonewton | 1 |
| 230 | necessary-swabs | 1 |
| 231 | ng/patch | 1 |
| 232 | nm.sec | 1 |
| 233 | nmol/µg | 1 |
| 234 | non-arti-medication | 1 |
| 235 | n·m·s | 1 |
| 236 | ois/malignancy | 1 |
| 237 | pachycnemis | 1 |
| 238 | pacos | 1 |
| 239 | paper-web | 1 |
| 240 | parotids | 1 |
| 241 | pathogens/patient | 1 |
| 242 | patients-62 | 1 |
| 243 | pg/ml+/-2.2 | 1 |
| 244 | phenazopyridino | 1 |
| 245 | picornavirus-positive | 1 |
| 246 | ppg/ml | 1 |
| 247 | ppvrs | 1 |
| 248 | pr-patients | 1 |
| 249 | regurgitations/day | 1 |
| 250 | retinol-allocated | 1 |
| 251 | rev·min | 1 |
| 252 | rounds/woman | 1 |
| 253 | samples/matrix/individual | 1 |
| 254 | sativi | 1 |
| 255 | sd10.6 | 1 |
| 256 | sd64.9 | 1 |
| 257 | slabs/group | 1 |
| 258 | snores/h | 1 |
| 259 | steps.min-1 | 1 |
| 260 | substances/player/match | 1 |
| 261 | successful-to | 1 |
| 262 | taxa/sample | 1 |
| 263 | to-0.4 | 1 |
| 264 | to10.2 | 1 |
| 265 | to14.7 | 1 |
| 266 | to16.7 | 1 |
| 267 | to7.3±0.9 | 1 |
| 268 | tp53wt/wt | 1 |
| 269 | uraermia | 1 |
| 270 | vanbreuseghemii | 1 |
| 271 | versusδ=1.9 | 1 |
| 272 | versusδ=5.4 | 1 |
| 273 | visits/habitant/year | 1 |
| 274 | visits/patient | 1 |
| 275 | vs.-0.8 | 1 |
| 276 | vs.-19.6 | 1 |
| 277 | vs.10.4 | 1 |
| 278 | vs.110.9 | 1 |
| 279 | vs.13.1 | 1 |
| 280 | vs.130.2 | 1 |
| 281 | vs.147 | 1 |
| 282 | vs.155 | 1 |
| 283 | vs.19.8 | 1 |
| 284 | vs.22.9 | 1 |
| 285 | vs.23.2 | 1 |
| 286 | vs.23.7 | 1 |
| 287 | vs.37.9 | 1 |
| 288 | vs.45.7 | 1 |
| 289 | vs.49.11 | 1 |
| 290 | vs.56.1 | 1 |
| 291 | vs.58.0 | 1 |
| 292 | vs.78.1 | 1 |
| 293 | vs.81±7 | 1 |
| 294 | web-paper | 1 |
| 295 | winter-calving | 1 |
| 296 | years+/-9.5 | 1 |
| 297 | yrs/7 | 1 |
| 298 | ±0.7ºc | 1 |
| 299 | ±0.877 | 1 |
| 300 | ±0.997 | 1 |
| 301 | ±1.163 | 1 |
| 302 | ±1.53 | 1 |
| 303 | ±11.07 | 1 |
| 304 | ±12.77 | 1 |
| 305 | ±16.9ng/g | 1 |
| 306 | ±18.80 | 1 |
| 307 | ±22.44 | 1 |
| 308 | ±6.62 | 1 |
| 309 | ±61.0 | 1 |
| 310 | ±69.5 | 1 |
| 311 | ±7.23 | 1 |
| 312 | ±8,2 | 1 |
| 313 | ±8.32 | 1 |
| 314 | µg/nostril | 1 |
| 315 | µmbc | 1 |
| 316 | μa/cm2 | 1 |
| 317 | μg/day/eye | 1 |
| 318 | μm=60 | 1 |
| 319 | μmol/g±3.9 | 1 |
| 320 | μmol/g±4.8 | 1 |
| 321 | μu/ml/min | 1 |
| 322 | –102.2 | 1 |
| 1 | % | 764,873 |
| 2 | +/-1.11 | 1 |
| 3 | +/-1.23 | 1 |
| 4 | +/-1.63 | 1 |
| 5 | +/-11.06 | 1 |
| 6 | +/-15.0cm/second | 1 |
| 7 | +/-17.8 | 1 |
| 8 | +/-23.9 | 1 |
| 9 | +/-23.90 | 1 |
| 10 | +/-3.33 | 1 |
| 11 | +/-4.81 | 1 |
| 12 | +/-6.78 | 1 |
| 13 | +/-8.92 | 1 |
| 14 | +0.3±5.8 | 1 |
| 15 | +2.10 | 1 |
| 16 | -/+11.8 | 1 |
| 17 | /+2.1 | 1 |
| 18 | /205 | 1 |
| 19 | /350 | 1 |
| 20 | 051.90 | 1 |
| 21 | 083 | 6 |
| 22 | 1.65-6.23 | 1 |
| 23 | 107+/-28.2 | 1 |
| 24 | 1361±405 | 1 |
| 25 | 1¯ | 1 |
| 26 | 205143 | 1 |
| 27 | 205402 | 1 |
| 28 | 207.76 | 1 |
| 29 | 287.12 | 1 |
| 30 | 34.4+/-3.5 | 1 |
| 31 | 38304-91-5 | 1 |
| 32 | 40.1±4.6 | 1 |
| 33 | 42430 | 1 |
| 34 | 49-1.22 | 1 |
| 35 | 642/µl | 1 |
| 36 | 75+/-19.7 | 1 |
| 37 | 763±3059 | 1 |
| 38 | 8.27±7.33 | 1 |
| 39 | 818.05±16 | 1 |
| 40 | 9/700 | 1 |
| 41 | =0.235-1.810 | 1 |
| 42 | adenocarciomas | 1 |
| 43 | african-american/101 | 1 |
| 44 | albendazole-allocated | 1 |
| 45 | alexandrine | 1 |
| 46 | angstroms/s | 1 |
| 47 | balloons/case | 1 |
| 48 | bpm/d | 1 |
| 49 | breaks/day | 1 |
| 50 | broilers/trial | 1 |
| 51 | bts/min | 2 |
| 52 | bursts/minute | 1 |
| 53 | cal/kg/d | 1 |
| 54 | calories/kg/d | 1 |
| 55 | caps/mm2 | 2 |
| 56 | cases/1291 | 1 |
| 57 | cells/µl/year | 1 |
| 58 | cfhn | 2 |
| 59 | cially | 1 |
| 60 | cigs/d | 2 |
| 61 | cm/cm² | 8 |
| 62 | cmlcs | 1 |
| 63 | conrols | 1 |
| 64 | cryotreatments | 2 |
| 65 | cyathiformis | 1 |
| 66 | cysts/animal | 1 |
| 67 | days.. | 1 |
| 68 | days/5.5 | 1 |
| 69 | days/person | 2 |
| 70 | days/person-year | 2 |
| 71 | deceased/moved | 1 |
| 72 | dilution-units | 1 |
| 73 | doth | 6 |
| 74 | dyn.cm.5 | 1 |
| 75 | edlund | 1 |
| 76 | electrocutions | 1 |
| 77 | embryo/recovery | 1 |
| 78 | emu/g | 5 |
| 79 | eu/liter | 3 |
| 80 | euro+/-539 | 1 |
| 81 | female/158 | 1 |
| 82 | females/74 | 1 |
| 83 | femtoliters | 1 |
| 84 | fibers/high | 1 |
| 85 | fibrillations/min | 1 |
| 86 | fmol/l | 1 |
| 87 | g/capsule | 1 |
| 88 | g/days | 1 |
| 89 | g/hm2 | 1 |
| 90 | g/kg.d | 1 |
| 91 | g/km/mo | 1 |
| 92 | g/m/hr | 2 |
| 93 | g/m2/hour | 1 |
| 94 | g/patient | 1 |
| 95 | g/supplement | 2 |
| 96 | g/visit | 1 |
| 97 | g/°c | 1 |
| 98 | gene-transcripts | 1 |
| 99 | girls/boys | 1 |
| 100 | gly/ser+ser/ser | 1 |
| 101 | gm/m2 | 12 |
| 102 | gpl-u/ml | 1 |
| 103 | gv/cm | 2 |
| 104 | gy/32 | 1 |
| 105 | gy/37 | 1 |
| 106 | g·°c·min | 2 |
| 107 | hallucinogen-naïve | 1 |
| 108 | hr*ng/l | 1 |
| 109 | injections/cord | 1 |
| 110 | injections/month | 2 |
| 111 | insa | 1 |
| 112 | interactions/patients | 2 |
| 113 | interventio | 1 |
| 114 | introns/gene | 1 |
| 115 | iti-esthetic | 1 |
| 116 | joules/point | 3 |
| 117 | k/gm2 | 1 |
| 118 | kb/s | 1 |
| 119 | kg-1·m-2 | 1 |
| 120 | kg/hm2n | 3 |
| 121 | kj.3.5 | 2 |
| 122 | kj/mole | 1 |
| 123 | kjmol-1 | 1 |
| 124 | kton/year | 1 |
| 125 | kω/□ | 1 |
| 126 | l/carcass | 1 |
| 127 | l/mn/m2 | 1 |
| 128 | landsnails | 1 |
| 129 | lipil® | 1 |
| 130 | liters/min.m2 | 1 |
| 131 | lmethane/kgbagasse | 1 |
| 132 | log10/g | 3 |
| 133 | lymphatics/high | 1 |
| 134 | m-ramirez | 1 |
| 135 | m/35f | 1 |
| 136 | macrophages/high | 1 |
| 137 | macrostemonis | 1 |
| 138 | male-45 | 1 |
| 139 | males/43 | 1 |
| 140 | may2005 | 1 |
| 141 | mc/da | 1 |
| 142 | mc/m2 | 1 |
| 143 | mcg·kg-1·d-1 | 2 |
| 144 | measurements/patient | 1 |
| 145 | men/109 | 1 |
| 146 | meq/100g | 6 |
| 147 | mg*hr/l | 2 |
| 148 | mg/animal/day | 2 |
| 149 | mg/dl+/-1.5 | 1 |
| 150 | mg/gcdw.h | 3 |
| 151 | mg/g·cr | 2 |
| 152 | mg/km | 2 |
| 153 | mg/lf | 1 |
| 154 | mg/mm | 1 |
| 155 | mgfemnp | 2 |
| 156 | mgh/l | 3 |
| 157 | mgi/kg/s | 1 |
| 158 | mgn/l | 1 |
| 159 | mgy.cm | 2 |
| 160 | mg·h/ml | 1 |
| 161 | mg×h/dl | 1 |
| 162 | microcarcinomata-1 | 1 |
| 163 | microg./min | 1 |
| 164 | microl/s | 1 |
| 165 | micromol/kg/day | 5 |
| 166 | micromol/l/min | 1 |
| 167 | micromoles/l | 1 |
| 168 | microns2 | 2 |
| 169 | millett | 1 |
| 170 | million/l | 1 |
| 171 | million/sample | 1 |
| 172 | millions/ml | 2 |
| 173 | min/hr/patient | 1 |
| 174 | min=treatment | 1 |
| 175 | mini-pbals | 1 |
| 176 | minutes+/-1.0 | 1 |
| 177 | minutes+/-1.8 | 1 |
| 178 | minutes/attack | 1 |
| 179 | mj/week | 1 |
| 180 | ml.m-2.h-1 | 2 |
| 181 | ml/kg/min+/-8.6 | 1 |
| 182 | ml/kgmin | 1 |
| 183 | ml·min-1·kg-1 | 2 |
| 184 | mm.hg | 1 |
| 185 | mm/1.2° | 1 |
| 186 | mmeq/l | 1 |
| 187 | mmhg+3.2 | 1 |
| 188 | mmhg+3.8 | 1 |
| 189 | mmhg/dbp-13.0 | 1 |
| 190 | mmhg/min/l | 1 |
| 191 | mmhg2 | 1 |
| 192 | mmhg² | 1 |
| 193 | mmhg·min | 3 |
| 194 | mm²/min | 2 |
| 195 | months/hrt | 2 |
| 196 | months/patient | 4 |
| 197 | mothers-infants | 2 |
| 198 | mpl-u/ml | 1 |
| 199 | mrem/mci | 1 |
| 200 | ms/∞ | 1 |
| 201 | mtechnetium | 1 |
| 202 | mu-g/12 | 1 |
| 203 | mu/dl | 1 |
| 204 | mu/m2/week | 2 |
| 205 | mu/minutes | 1 |
| 206 | mumol/minute | 1 |
| 207 | mw.cm-3 | 1 |
| 208 | mxs-2 | 1 |
| 209 | n/cm² | 2 |
| 210 | nanonewton | 1 |
| 211 | necessary-swabs | 1 |
| 212 | ng*hour/ml | 6 |
| 213 | ng/microu | 2 |
| 214 | ng/patch | 1 |
| 215 | ngy/h | 2 |
| 216 | nm.sec | 1 |
| 217 | nmol/kg.day-1 | 4 |
| 218 | nmol/µg | 1 |
| 219 | nmol·l | 6 |
| 220 | non-arti-medication | 1 |
| 221 | ntu/ml | 4 |
| 222 | n·m·s | 1 |
| 223 | ois/malignancy | 1 |
| 224 | pachycnemis | 1 |
| 225 | pacos | 1 |
| 226 | paper-web | 1 |
| 227 | parotids | 1 |
| 228 | pathogens/patient | 1 |
| 229 | patients-62 | 1 |
| 230 | pg/ml+/-2.2 | 1 |
| 231 | phenazopyridino | 1 |
| 232 | picornavirus-positive | 1 |
| 233 | pkat/mg | 2 |
| 234 | post-clp | 3 |
| 235 | ppg/ml | 1 |
| 236 | ppvrs | 1 |
| 237 | pr-patients | 1 |
| 238 | regurgitations/day | 1 |
| 239 | residents/program | 2 |
| 240 | retinol-allocated | 1 |
| 241 | rev·min | 1 |
| 242 | rounds/woman | 1 |
| 243 | samples/matrix/individual | 1 |
| 244 | sativi | 1 |
| 245 | sd10.6 | 1 |
| 246 | sd64.9 | 1 |
| 247 | slabs/group | 1 |
| 248 | smd-pds | 4 |
| 249 | snores/h | 1 |
| 250 | steps.min-1 | 1 |
| 251 | substances/player/match | 1 |
| 252 | successful-to | 1 |
| 253 | taxa/sample | 1 |
| 254 | to-0.4 | 1 |
| 255 | to10.2 | 1 |
| 256 | to14.7 | 1 |
| 257 | to16.7 | 1 |
| 258 | to7.3±0.9 | 1 |
| 259 | tp53wt/wt | 1 |
| 260 | u/horse/day | 2 |
| 261 | units/dl | 2 |
| 262 | uraermia | 1 |
| 263 | utis/patient | 2 |
| 264 | uygurs | 2 |
| 265 | v194 | 3 |
| 266 | vanbreuseghemii | 1 |
| 267 | versusδ=1.9 | 1 |
| 268 | versusδ=5.4 | 1 |
| 269 | visits/habitant/year | 1 |
| 270 | visits/patient | 1 |
| 271 | vs.-0.8 | 1 |
| 272 | vs.-19.6 | 1 |
| 273 | vs.10.4 | 1 |
| 274 | vs.110.9 | 1 |
| 275 | vs.13.1 | 1 |
| 276 | vs.130.2 | 1 |
| 277 | vs.147 | 1 |
| 278 | vs.155 | 1 |
| 279 | vs.19.8 | 1 |
| 280 | vs.22.9 | 1 |
| 281 | vs.23.2 | 1 |
| 282 | vs.23.7 | 1 |
| 283 | vs.37.9 | 1 |
| 284 | vs.45.7 | 1 |
| 285 | vs.49.11 | 1 |
| 286 | vs.56.1 | 1 |
| 287 | vs.58.0 | 1 |
| 288 | vs.78.1 | 1 |
| 289 | vs.81±7 | 1 |
| 290 | web-paper | 1 |
| 291 | winter-calving | 1 |
| 292 | y/o | 8 |
| 293 | years+/-9.5 | 1 |
| 294 | yrs/7 | 1 |
| 295 | ±0.7ºc | 1 |
| 296 | ±0.877 | 1 |
| 297 | ±0.997 | 1 |
| 298 | ±1.163 | 1 |
| 299 | ±1.53 | 1 |
| 300 | ±11.07 | 1 |
| 301 | ±12.77 | 1 |
| 302 | ±16.9ng/g | 1 |
| 303 | ±18.80 | 1 |
| 304 | ±22.44 | 1 |
| 305 | ±6.62 | 1 |
| 306 | ±61.0 | 1 |
| 307 | ±69.5 | 1 |
| 308 | ±7.23 | 1 |
| 309 | ±8,2 | 1 |
| 310 | ±8.32 | 1 |
| 311 | µg/nostril | 1 |
| 312 | µmbc | 1 |
| 313 | μa/cm2 | 1 |
| 314 | μg/8h | 2 |
| 315 | μg/day/eye | 1 |
| 316 | μg/ml*h | 3 |
| 317 | μm=60 | 1 |
| 318 | μmol/g±3.9 | 1 |
| 319 | μmol/g±4.8 | 1 |
| 320 | μmoles/liter | 2 |
| 321 | μu/ml/min | 1 |
| 322 | –102.2 | 1 |
| 1 | % | 764,873 |
| 2 | days.. | 1 |
| 3 | minutes+/-1.0 | 1 |
| 4 | ±61.0 | 1 |
| 5 | mmhg/dbp-13.0 | 1 |
| 6 | vs.58.0 | 1 |
| 7 | 9/700 | 1 |
| 8 | +2.10 | 1 |
| 9 | =0.235-1.810 | 1 |
| 10 | 42430 | 1 |
| 11 | /350 | 1 |
| 12 | μm=60 | 1 |
| 13 | ±18.80 | 1 |
| 14 | 051.90 | 1 |
| 15 | +/-23.90 | 1 |
| 16 | microcarcinomata-1 | 1 |
| 17 | mcg·kg-1·d-1 | 2 |
| 18 | ml·min-1·kg-1 | 2 |
| 19 | ml.m-2.h-1 | 2 |
| 20 | kjmol-1 | 1 |
| 21 | steps.min-1 | 1 |
| 22 | nmol/kg.day-1 | 4 |
| 23 | /+2.1 | 1 |
| 24 | vs.13.1 | 1 |
| 25 | vs.56.1 | 1 |
| 26 | vs.78.1 | 1 |
| 27 | african-american/101 | 1 |
| 28 | +/-1.11 | 1 |
| 29 | vs.49.11 | 1 |
| 30 | +/-4.81 | 1 |
| 31 | cases/1291 | 1 |
| 32 | ±8,2 | 1 |
| 33 | kg-1·m-2 | 1 |
| 34 | mxs-2 | 1 |
| 35 | to10.2 | 1 |
| 36 | vs.130.2 | 1 |
| 37 | pg/ml+/-2.2 | 1 |
| 38 | –102.2 | 1 |
| 39 | mmhg+3.2 | 1 |
| 40 | vs.23.2 | 1 |
| 41 | 107+/-28.2 | 1 |
| 42 | 205402 | 1 |
| 43 | 287.12 | 1 |
| 44 | mu-g/12 | 1 |
| 45 | 49-1.22 | 1 |
| 46 | ±8.32 | 1 |
| 47 | gy/32 | 1 |
| 48 | patients-62 | 1 |
| 49 | ±6.62 | 1 |
| 50 | +/-8.92 | 1 |
| 51 | mmhg2 | 1 |
| 52 | liters/min.m2 | 1 |
| 53 | mc/m2 | 1 |
| 54 | gm/m2 | 12 |
| 55 | l/mn/m2 | 1 |
| 56 | μa/cm2 | 1 |
| 57 | k/gm2 | 1 |
| 58 | g/hm2 | 1 |
| 59 | caps/mm2 | 2 |
| 60 | microns2 | 2 |
| 61 | mw.cm-3 | 1 |
| 62 | +/-1.23 | 1 |
| 63 | 1.65-6.23 | 1 |
| 64 | ±7.23 | 1 |
| 65 | +/-3.33 | 1 |
| 66 | 8.27±7.33 | 1 |
| 67 | males/43 | 1 |
| 68 | 205143 | 1 |
| 69 | ±1.53 | 1 |
| 70 | +/-1.63 | 1 |
| 71 | ±1.163 | 1 |
| 72 | 083 | 6 |
| 73 | to-0.4 | 1 |
| 74 | vs.10.4 | 1 |
| 75 | versusδ=5.4 | 1 |
| 76 | ±22.44 | 1 |
| 77 | females/74 | 1 |
| 78 | v194 | 3 |
| 79 | 38304-91-5 | 1 |
| 80 | mg/dl+/-1.5 | 1 |
| 81 | 34.4+/-3.5 | 1 |
| 82 | kj.3.5 | 2 |
| 83 | days/5.5 | 1 |
| 84 | years+/-9.5 | 1 |
| 85 | ±69.5 | 1 |
| 86 | dyn.cm.5 | 1 |
| 87 | may2005 | 1 |
| 88 | /205 | 1 |
| 89 | 1361±405 | 1 |
| 90 | male-45 | 1 |
| 91 | vs.155 | 1 |
| 92 | sd10.6 | 1 |
| 93 | 40.1±4.6 | 1 |
| 94 | ml/kg/min+/-8.6 | 1 |
| 95 | vs.-19.6 | 1 |
| 96 | +/-11.06 | 1 |
| 97 | 818.05±16 | 1 |
| 98 | 207.76 | 1 |
| 99 | vs.23.7 | 1 |
| 100 | to14.7 | 1 |
| 101 | vs.45.7 | 1 |
| 102 | to16.7 | 1 |
| 103 | 75+/-19.7 | 1 |
| 104 | yrs/7 | 1 |
| 105 | ±11.07 | 1 |
| 106 | gy/37 | 1 |
| 107 | vs.147 | 1 |
| 108 | ±12.77 | 1 |
| 109 | ±0.877 | 1 |
| 110 | ±0.997 | 1 |
| 111 | vs.81±7 | 1 |
| 112 | vs.-0.8 | 1 |
| 113 | minutes+/-1.8 | 1 |
| 114 | -/+11.8 | 1 |
| 115 | mmhg+3.8 | 1 |
| 116 | μmol/g±4.8 | 1 |
| 117 | +0.3±5.8 | 1 |
| 118 | +/-17.8 | 1 |
| 119 | vs.19.8 | 1 |
| 120 | female/158 | 1 |
| 121 | +/-6.78 | 1 |
| 122 | vs.110.9 | 1 |
| 123 | to7.3±0.9 | 1 |
| 124 | versusδ=1.9 | 1 |
| 125 | vs.22.9 | 1 |
| 126 | +/-23.9 | 1 |
| 127 | μmol/g±3.9 | 1 |
| 128 | sd64.9 | 1 |
| 129 | vs.37.9 | 1 |
| 130 | men/109 | 1 |
| 131 | euro+/-539 | 1 |
| 132 | 763±3059 | 1 |
| 133 | mc/da | 1 |
| 134 | uraermia | 1 |
| 135 | insa | 1 |
| 136 | paper-web | 1 |
| 137 | µmbc | 1 |
| 138 | nm.sec | 1 |
| 139 | iti-esthetic | 1 |
| 140 | g/°c | 1 |
| 141 | ±0.7ºc | 1 |
| 142 | g/kg.d | 1 |
| 143 | cal/kg/d | 1 |
| 144 | calories/kg/d | 1 |
| 145 | bpm/d | 1 |
| 146 | cigs/d | 2 |
| 147 | albendazole-allocated | 1 |
| 148 | retinol-allocated | 1 |
| 149 | deceased/moved | 1 |
| 150 | +/-15.0cm/second | 1 |
| 151 | edlund | 1 |
| 152 | injections/cord | 1 |
| 153 | kj/mole | 1 |
| 154 | taxa/sample | 1 |
| 155 | million/sample | 1 |
| 156 | g/capsule | 1 |
| 157 | introns/gene | 1 |
| 158 | alexandrine | 1 |
| 159 | balloons/case | 1 |
| 160 | lmethane/kgbagasse | 1 |
| 161 | mumol/minute | 1 |
| 162 | bursts/minute | 1 |
| 163 | picornavirus-positive | 1 |
| 164 | hallucinogen-naïve | 1 |
| 165 | μg/day/eye | 1 |
| 166 | m/35f | 1 |
| 167 | mg/lf | 1 |
| 168 | log10/g | 3 |
| 169 | ±16.9ng/g | 1 |
| 170 | emu/g | 5 |
| 171 | meq/100g | 6 |
| 172 | mm.hg | 1 |
| 173 | pkat/mg | 2 |
| 174 | winter-calving | 1 |
| 175 | nmol/µg | 1 |
| 176 | μg/ml*h | 3 |
| 177 | mg/gcdw.h | 3 |
| 178 | snores/h | 1 |
| 179 | ngy/h | 2 |
| 180 | μg/8h | 2 |
| 181 | substances/player/match | 1 |
| 182 | ng/patch | 1 |
| 183 | lymphatics/high | 1 |
| 184 | macrophages/high | 1 |
| 185 | fibers/high | 1 |
| 186 | injections/month | 2 |
| 187 | doth | 6 |
| 188 | mrem/mci | 1 |
| 189 | vanbreuseghemii | 1 |
| 190 | sativi | 1 |
| 191 | minutes/attack | 1 |
| 192 | mu/m2/week | 2 |
| 193 | mj/week | 1 |
| 194 | hr*ng/l | 1 |
| 195 | mgh/l | 3 |
| 196 | fmol/l | 1 |
| 197 | mgn/l | 1 |
| 198 | mmhg/min/l | 1 |
| 199 | million/l | 1 |
| 200 | mmeq/l | 1 |
| 201 | mg*hr/l | 2 |
| 202 | micromoles/l | 1 |
| 203 | broilers/trial | 1 |
| 204 | cysts/animal | 1 |
| 205 | samples/matrix/individual | 1 |
| 206 | mg×h/dl | 1 |
| 207 | units/dl | 2 |
| 208 | mu/dl | 1 |
| 209 | µg/nostril | 1 |
| 210 | ppg/ml | 1 |
| 211 | mg·h/ml | 1 |
| 212 | ng*hour/ml | 6 |
| 213 | millions/ml | 2 |
| 214 | gpl-u/ml | 1 |
| 215 | mpl-u/ml | 1 |
| 216 | ntu/ml | 4 |
| 217 | 642/µl | 1 |
| 218 | nmol·l | 6 |
| 219 | residents/program | 2 |
| 220 | mgy.cm | 2 |
| 221 | gv/cm | 2 |
| 222 | mg/km | 2 |
| 223 | mg/mm | 1 |
| 224 | mtechnetium | 1 |
| 225 | kg/hm2n | 3 |
| 226 | rounds/woman | 1 |
| 227 | cfhn | 2 |
| 228 | microg./min | 1 |
| 229 | micromol/l/min | 1 |
| 230 | μu/ml/min | 1 |
| 231 | fibrillations/min | 1 |
| 232 | bts/min | 2 |
| 233 | mm²/min | 2 |
| 234 | ml/kgmin | 1 |
| 235 | g·°c·min | 2 |
| 236 | mmhg·min | 3 |
| 237 | rev·min | 1 |
| 238 | non-arti-medication | 1 |
| 239 | days/person | 2 |
| 240 | nanonewton | 1 |
| 241 | y/o | 8 |
| 242 | interventio | 1 |
| 243 | g/km/mo | 1 |
| 244 | phenazopyridino | 1 |
| 245 | successful-to | 1 |
| 246 | post-clp | 3 |
| 247 | mgfemnp | 2 |
| 248 | slabs/group | 1 |
| 249 | days/person-year | 2 |
| 250 | cells/µl/year | 1 |
| 251 | kton/year | 1 |
| 252 | visits/habitant/year | 1 |
| 253 | mg/g·cr | 2 |
| 254 | web-paper | 1 |
| 255 | gly/ser+ser/ser | 1 |
| 256 | μmoles/liter | 2 |
| 257 | eu/liter | 3 |
| 258 | g/m/hr | 2 |
| 259 | g/m2/hour | 1 |
| 260 | kb/s | 1 |
| 261 | mgi/kg/s | 1 |
| 262 | microl/s | 1 |
| 263 | angstroms/s | 1 |
| 264 | adenocarciomas | 1 |
| 265 | necessary-swabs | 1 |
| 266 | cmlcs | 1 |
| 267 | parotids | 1 |
| 268 | smd-pds | 4 |
| 269 | mu/minutes | 1 |
| 270 | pachycnemis | 1 |
| 271 | cyathiformis | 1 |
| 272 | macrostemonis | 1 |
| 273 | mini-pbals | 1 |
| 274 | landsnails | 1 |
| 275 | conrols | 1 |
| 276 | electrocutions | 1 |
| 277 | pacos | 1 |
| 278 | femtoliters | 1 |
| 279 | uygurs | 2 |
| 280 | ppvrs | 1 |
| 281 | l/carcass | 1 |
| 282 | dilution-units | 1 |
| 283 | mothers-infants | 2 |
| 284 | pr-patients | 1 |
| 285 | interactions/patients | 2 |
| 286 | cryotreatments | 2 |
| 287 | gene-transcripts | 1 |
| 288 | g/days | 1 |
| 289 | girls/boys | 1 |
| 290 | n·m·s | 1 |
| 291 | g/visit | 1 |
| 292 | g/patient | 1 |
| 293 | min/hr/patient | 1 |
| 294 | months/patient | 4 |
| 295 | utis/patient | 2 |
| 296 | pathogens/patient | 1 |
| 297 | visits/patient | 1 |
| 298 | measurements/patient | 1 |
| 299 | g/supplement | 2 |
| 300 | min=treatment | 1 |
| 301 | joules/point | 3 |
| 302 | months/hrt | 2 |
| 303 | millett | 1 |
| 304 | tp53wt/wt | 1 |
| 305 | ng/microu | 2 |
| 306 | u/horse/day | 2 |
| 307 | micromol/kg/day | 5 |
| 308 | mg/animal/day | 2 |
| 309 | breaks/day | 1 |
| 310 | regurgitations/day | 1 |
| 311 | ois/malignancy | 1 |
| 312 | cially | 1 |
| 313 | embryo/recovery | 1 |
| 314 | m-ramirez | 1 |
| 315 | ms/∞ | 1 |
| 316 | kω/□ | 1 |
| 317 | lipil® | 1 |
| 318 | 1¯ | 1 |
| 319 | mm/1.2° | 1 |
| 320 | mmhg² | 1 |
| 321 | cm/cm² | 8 |
| 322 | n/cm² | 2 |